The drug, JSKN003, showed promising early efficacy in colorectal cancer patients in China in a Phase I/II trial.

Novartis will acquire the firm's neuroscience assets. Meanwhile, Avidity will separate and transfer its precision cardiology programs to a subsidiary.

Intellia disclosed that a patient treated with nexiguran ziclumeran as part of the Phase III MAGNITUDE trial has been hospitalized.

In a Phase II trial, 23 percent of patients achieved complete remission plus complete remission with partial hematologic recovery on Revuforj.

The payment was triggered because Kura dosed the first AML patient in a Phase III trial of the menin inhibitor.

AGC Biologics will help the company develop and manufacture RDP-101 in line with FDA standards and for the commercial market.

A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...

The firm also said this week it will conduct a pivotal study next year of its PRMT5 inhibitor in MTAP-deleted pancreatic cancer.

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.

Amid steady Q3 growth, Roche's giredestrant-Afinitor combo extended survival in advanced ER-positive, HER2-negative early breast cancer.